Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Austria Health Focus.
Progress in clinical development for Alzheimer’s and other indications: Galimedix Therapeutics successfully completes Phase 1 study with oral small molecule, GAL-101, an amyloid beta aggregation modulator
GAL-101 was well tolerated; excellent safety and pharmacokinetic profile strongly support oral administration GAL-101 effectively crosses the blood-brain barrier, supporting further development in Alzheimer’s disease A Phase 2 trial in Alzheimer’s...
Lexicon Pharmaceuticals to Present Additional Clinical Data on Pilavapadin at Three Upcoming Medical Meetings
Presentations collectively highlight pilavapadin’s potential to improve pain management care for patients with diabetic peripheral neuropathic pain (DPNP) Breadth of the data across Phase 2 program to be discussed at Arrowhead’s 19th Annual Pain...
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
LONDON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Administration (“FDA”) has approved Obagi® saypha® MagIQ™ injectable...
DNA Vaccine Market Size to Expect USD 1041.68 Million by 2034
Ottawa, Sept. 15, 2025 (GLOBE NEWSWIRE) -- According to a study by Towards Healthcare, a sister company of Precedence Research, the DNA vaccine market size was estimated at USD 553.89 million in 2024. With rising demand and ongoing advancements,...
Biomed Industries to Present Phase 2 Results on NA-931-An Oral Alternative to Injectables for Obesity- EASD 2025 Austria
Biomed Industries, Inc. to Present Phase 2 Results on NA-931-a First-in Class Alternative to Injectables for the Treatment of Obesity-EASD 2025- Vienna-Austria SAN JOSE, CA, UNITED STATES, September 8, 2025 /EINPresswire.com/ -- Biomed...
Leading Austrian Pathology Laboratory Group Chooses PathAI’s AISight® Dx to Accelerate Digital Pathology and Advanced Diagnostics
BOSTON and VIENNA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in artificial intelligence and digital pathology solutions, today announced multi-year partnerships with a group of pioneering Austrian pathology laboratories to deploy...
SPS expands Philips SpeechLive with ambient medical AI documentation, powered by Corti
Philips SpeechLive adds Corti’s ambient medical AI, delivering real-time clinical documentation to ease workloads and boost care. VIENNA, AUSTRIA, September 3, 2025 /EINPresswire.com/ -- Speech Processing Solutions (SPS), the global leader...
China Warns Europe Against Agreements Undermining Beijing Interests
(MENAFN) China's Foreign Minister, Wang Yi, issued a stern warning to European nations on Friday, cautioning against "mistaken" agreements that could undermine Beijing’s interests. During a meeting with Austrian Foreign Minister Beate...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
EVIDENT and Siemens Healthineers Join Efforts to Advance Digital Pathology at Klinikum Ludwigshafen
WALTHAM, Mass. and ERLANGEN, Germany and LUDWIGSHAFEN, Germany, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Siemens Healthineers, a leading global medical technology company, and Evident — which recently acquired Pramana, an AI-enabled health tech company...
Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI® (lecanemab)
TOKYO and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher,...
New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High-Risk or Very High-Risk Patients Based on REDUCE-IT -- DUBLIN and BRIDGEWATER, N.J., Aug. 30, 2025 (GLOBE NEWSWIRE)...
AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service
Oxford University-led AMALFI clinical trial results presented at the European Society of Cardiology (ESC) Congress 2025 and published in the Journal of the American Medical Association (JAMA). AMALFI tested whether home-based, self-applied use of...
Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria
Led by Prof. Dr. Marianne Brodmann, PI of clinical studies for the Lumee™ Oxygen CE Mark, collaboration includes practice adoption and platform integration in cases and clinical study programs BERKELEY, Calif, Aug. 27, 2025 (GLOBE NEWSWIRE) --...
Casing Cementation Hardware Market Projected to Reach USD 4.62 Billion by 2032 at 5.1% CAGR To Forecast 2025-2032
Casing Cementation Hardware Market revenue is expected to grow by CAGR 5.1% from 2025 to 2032 and reach nearly USD 4.62 Billion in 2032. WILMINGTON, DE, UNITED STATES, September 15, 2025 /EINPresswire.com/ -- The Casing Cementation Hardware...
Skye Bioscience to Participate in Upcoming Investment and Medical Conferences
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that...
Revolutionising Sustainable Construction: DesertBoard’s Palm Waste Innovation Debuts at Architect@Work Hamburg
HAMBURG, Germany, Sept. 15, 2025 (GLOBE NEWSWIRE) -- DesertBoard, the UAE-based innovator in sustainable building materials, will make its European debut at Architect@Work Hamburg (17–18 September, Hall B7), presenting its flagship innovation,...
Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, will present clinical and preclinical data from...
Candera CGI Studio Meets TI AM62P: Fast, Safe, and Scalable Automotive HMI Development
Candera CGI Studio now supports TI’s AM62P SoC, enabling fast, safe, and scalable HMI development for next-gen automotive displays. LINZ, UPPER AUSTRIA, AUSTRIA, September 9, 2025 /EINPresswire.com/ -- Candera, a leading provider of HMI...
Amy Lawton Receives CEU’s 2025 European Award for Excellence in Teaching
VIENNA , AUSTRIA, September 3, 2025 /EINPresswire.com/ -- Central European University (CEU) has awarded the fourteenth annual European Award for Excellence in Teaching in the Social Sciences and Humanities to Dr. Amy Lawton, Senior Lecturer in...
Baby Pacifier Market Size to Reach USD 824.11 Million by 2034, Growing at 3.90% CAGR
The global baby pacifier market size was worth around USD 562.12 million in 2024 and is predicted to grow to around USD 824.11 million by 2034 PUNE, MAHARASHTRA, INDIA, September 10, 2025 /EINPresswire.com/ -- Executive Summary The global baby...